| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial
|
Johnston, Patrick B
|
|
2016
|
3 |
7 |
p. e309-e316
nvt p.
|
artikel
|
| 2 |
Improved survival with salvage autologous stem-cell transplantation in myeloma
|
Holstein, Sarah A
|
|
2016
|
3 |
7 |
p. e306-e307
nvt p.
|
artikel
|
| 3 |
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial
|
Delaney, Colleen
|
|
2016
|
3 |
7 |
p. e330-e339
nvt p.
|
artikel
|
| 4 |
Maintenance therapy in CLL: resolving the controversy
|
Tam, Constantine S
|
|
2016
|
3 |
7 |
p. e304-e305
nvt p.
|
artikel
|
| 5 |
mTOR inhibition in diffuse large B-cell lymphoma: new hope?
|
Hess, Georg
|
|
2016
|
3 |
7 |
p. e302-e303
nvt p.
|
artikel
|
| 6 |
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
|
Greil, Richard
|
|
2016
|
3 |
7 |
p. e317-e329
nvt p.
|
artikel
|
| 7 |
The complex genetic landscape of acute myeloid leukaemia
|
The Lancet Haematology,
|
|
2016
|
3 |
7 |
p. e301-
1 p.
|
artikel
|
| 8 |
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial
|
Cook, Gordon
|
|
2016
|
3 |
7 |
p. e340-e351
nvt p.
|
artikel
|
| 9 |
The 52nd annual meeting of the American Society of Clinical Oncology
|
Smith, Lan-Lan
|
|
2016
|
3 |
7 |
p. e308-
1 p.
|
artikel
|
Tijdschrift beschrijving